摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

1-[(3-chlorophenyl)methyl]-9-nitro-3,4-dihydro-2H-benzothiopheno[3,2-e][1,4]diazepin-5-one

中文名称
——
中文别名
——
英文名称
1-[(3-chlorophenyl)methyl]-9-nitro-3,4-dihydro-2H-benzothiopheno[3,2-e][1,4]diazepin-5-one
英文别名
1-[(3-chlorophenyl)methyl]-9-nitro-3,4-dihydro-2H-[1]benzothiolo[3,2-e][1,4]diazepin-5-one
1-[(3-chlorophenyl)methyl]-9-nitro-3,4-dihydro-2H-benzothiopheno[3,2-e][1,4]diazepin-5-one化学式
CAS
——
化学式
C18H14ClN3O3S
mdl
——
分子量
387.8
InChiKey
FHLQYEXSKHKXMF-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    4.4
  • 重原子数:
    26
  • 可旋转键数:
    2
  • 环数:
    4.0
  • sp3杂化的碳原子比例:
    0.17
  • 拓扑面积:
    106
  • 氢给体数:
    1
  • 氢受体数:
    5

文献信息

  • PYRROLIDINE DERIVATIVES HAVING PHOSPHOLIPASE A2 INHIBITORY ACTIVITY
    申请人:SHIONOGI & CO., LTD.
    公开号:EP0976748A1
    公开(公告)日:2000-02-02
    A compound represented by the formula (I): wherein, for example, R1 is optionally substituted aralkyl, Z is nitrogen atom which optionally substituted with alkyl, X1 is -CH2NHCO-, X2 is phenylene, X3 is a bond, Y2 is optionally substituted aryl, B is oxygen atom, its pharmaceutically acceptable salt, or hydrate thereof and a pharmaceutical composition which contains them as an active ingredient.
    由式(I)代表的化合物: 其中,例如,R1 是任选取代的芳烷基,Z 是任选被烷基取代的氮原子,X1 是-CH2NHCO-,X2 是亚苯基,X3 是键,Y2 是任选取代的芳基,B 是氧原子、其药学上可接受的盐或合物,以及含有它们作为活性成分的药物组合物。
  • PREVENTIVES OR REMEDIES FOR ARRHYTHMIA
    申请人:SHIONOGI & CO., LTD.
    公开号:EP1240906A1
    公开(公告)日:2002-09-18
    A composition for treating or preventing arrhythmia containing as an active ingredient a cPLA2 inhibitor, for example a compound represented by formula (I): wherein R1 is optionally substituted aralkyl or the like; Z is -S- or the like; X1 is -(CH2)s-N(R18)-CO- (wherein R18 is hydrogen atom or the like, s is an integer of 0 to 3) or the like; X2 is optionally substituted arylene or the like; X3 is a bond or the like; A, B, and E are each independently oxygen atom or sulfur atom; D is hydrogen atom or the like; Y1 is -(CH2)mCO- (m is an integer of 0 to 3) or the like; Y2 is optionally substituted aryl or the like.
    一种治疗或预防心律失常的组合物,其活性成分含有 cPLA2 抑制剂,例如由式 (I) 代表的化合物: 其中 R1 是任选取代的芳烷基或类似物; Z 是-S-或类似物; X1 是-(CH2)s-N(R18)-CO-(其中 R18 是氢原子或类似物,s 是 0 至 3 的整数)或类似物; X2 是任选取代的芳烯或类似物;X3是键或类似物;A、B和E各自独立地是氧原子或原子;D是氢原子或类似物;Y1是-( )mCO- (m是0至3的整数)或类似物;Y2是任选取代的芳基或类似物。
  • Diazepinones as antiviral agents
    申请人:——
    公开号:US20040116410A1
    公开(公告)日:2004-06-17
    The invention is novel compounds of formula (I) which exhibit an improved therapeutic index and improved metabolic stability which are useful in the treatment and/or prevention of herpes viral infections. Novel intermediates useful in the synthesis of the final compounds are also part of the invention.
  • US6147100A
    申请人:——
    公开号:US6147100A
    公开(公告)日:2000-11-14
  • US6924301B1
    申请人:——
    公开号:US6924301B1
    公开(公告)日:2005-08-02
查看更多

同类化合物

阿帕泛 贝帕泛 苯他西泮 环氯唑仑 溴替唑仑 氯噻西泮 司替帕泛 去甲氯噻西泮; 去甲基氯噻西泮; 5-(2-氯苯基)-7-乙基-1,3-二氢-2H-噻吩并[2,3-e][1,4]二氮杂卓-2-酮 伊拉帕泛 乙替唑仑 alpha-羟基依替唑仑 [(R,S)-4-(4-氯苯基)-2,3,9-三甲基-6H-1-硫杂-5,7,8,9a-四氮杂-环戊环[e]氮杂-6-基]-乙酸叔丁酯 PROTACBET结合部分2 N-(4-叔-丁基苯基)-6-(2-氯苯基)-1-甲基-7,10-二氢-4H-吡啶并[4',3':4,5]噻吩并[3,2-f][1,2,4]三唑并[4,3-a][1,4]二氮杂卓-9(8H)-甲酰胺 7-氯-5-(2-氯苯基)-1,3-二氢-2H-噻吩并-(2,3-e)-(1,4)-二氮杂卓-2-硫酮 7-乙基-5-苯基-3,4-二氢噻吩并[3,2-f][1,4]二氮杂卓-2-酮 7-乙基-5-(2-氟苯基)-1,3-二氢-2H-噻吩并[2,3-e]-1,4-二氮杂卓-2-酮 6-(2-氯苯基)-1-甲基-N-[4-(三氟甲基)苯基]-7,10-二氢-4H-吡啶并[4',3':4,5]噻吩并[3,2-f][1,2,4]三唑并[4,3-a][1,4]二氮杂卓-9(8H)-甲硫代酰胺 6-(2-氯苯基)-1-甲基-N-(1-甲基-2-苯基乙基)-7,10-二氢-4H-吡啶并[4',3':4,5]噻吩并[3,2-f][1,2,4]三唑并[4,3-a][1,4]二氮杂卓-9(8H)-甲硫代酰胺 5-(2-氯苯基)-7-乙基-1H-噻吩并[2,3-e][1,4]二氮杂卓-2(3h)-硫酮 5-(2-氯苯基)-2,3-二氢-2-氧代-1H-噻吩并[2,3-e]-1,4-二氮杂卓-7-丙酸甲酯 5,6-二氢-5-甲基-6-氧代-4H-i咪唑并[1,5-a]噻吩并[2,3-f][1,4]二氮杂-3-羧酸1,1-二甲基乙酯 4-甲基-3,4-二氢-1H-噻吩并[2,3-E][1,4]二氮杂-2,5-二酮 4-(2-氯苯基)-N-(2-羟基乙基)-9-甲基-6H-噻吩并(3,2-f)(1,2,4)三唑并(4,3-a)(1,4)二氮杂卓-2-丙酰胺 4-(2-氯苯基)-9-甲基-6H-噻吩并[3,2-f][1,2,4]三唑并[4,3-a][1,4]二氮杂卓-2-丙酸甲酯 4-(2-氯苯基)-9-甲基-6H-噻吩并[3,2-f][1,2,4]三唑并[4,3-a][1,4]二氮杂卓-2-丙酸 4-(2-氯苯基)-9-甲基-2-(4-吗啉-4-基-4-羰基丁基)-6H-噻吩并[3,2-f][1,2,4]三唑并[4,3-a][1,4]二氮杂卓 3-噻丁烷酮,2-氯-2-(1-甲基乙基)- 3-[4-(2-氯苯基)-9-甲基-6H-噻吩并[3,2-f][1,2,4]三唑并[4,3-a][1,4]二氮杂卓-2-基]-2-丙炔-1-醇 2-((6R)-4-(4-氯苯基)-2,3,9-三甲基-6H-噻吩并[3,2-F]的[1,2,4 1H-噻吩并[2,3-e]-1,4-二氮杂卓-2,3-二酮,1-甲基-5-苯基-,3-肟 (S)-4-(4-氯苯基)-N-(4-羟基苯基)-2,3,9-三甲基-6H-噻吩并[3,2-F][1,2,4]三唑并[4,3-A][1,4]二氮杂卓-6-乙酰胺 (S)-2-(5-(4-氯苯基)-6,7-二甲基-2-氧代-2,3-二氢-1H-噻吩并[2,3-E] (S)-2-(4-(4-氯苯基)-2-(羟甲基)-3,9-二甲基-6H-噻吩并[3,2-F][1,2,4]三唑并[4,3]-A][1,4]二氮杂卓-6-基)乙酸甲酯 (S)-(+)-2-(4-(4-氯苯基)-2,3,9-三甲基-6H-噻吩并[3,2-F][1,2,4]三唑并[4,3-A][1,4]二氮杂卓-6-基)乙酸叔丁酯 (-)-JQ-1; (R)-(-)2-(4-(4-氯苯基)-2,3,9-三甲基-6H-噻吩并[3,2-f][1,2,4]三唑并[4,3-a][1,4]二氮杂环庚烷-6-基)乙酸叔丁酯 (+)-JQ1羧酸 tetrahydro-furan-3-carboxylic acid [7-bromo-5-(2-chloro-phenyl)-1,3-dihydro-thieno[2,3-e][1,4]diazepin-2-ylidene]-hydrazide 2-Bromo-4-(2-chloro-phenyl)-8-methyl-6H,8H-1-thia-5,7,8,9a-tetraaza-cyclopenta[e]azulen-9-one 4-(2-chloro-phenyl)-2-ethyl-9-oxo-6H-thieno[3,2-f][1,2,4]triazolo[4,3-a][1,4]diazepine-8-carboxylic acid methylamide piperidine-4-carboxylic acid [7-bromo-5-(2-chloro-phenyl)-1,3-dihydro-thieno[2,3-e][1,4]diazepin-2-ylidene]-hydrazide 9-(2-chlorophenyl)-3-methyl-17-thia-2,4,5,8-tetrazatetracyclo[8.7.0.02,6.011,16]heptadeca-1(10),3,5,11(16)-tetraene N,N-Diethyl-N'-thieno[3,2-b]pyrrolizin-(4Z)-ylidene-propane-1,3-diamine 2-bromo-4-(2-chloro-phenyl)-9-tetrahydrofuran-3-yl-6H-thieno[3,2-f][1,2,4]triazolo[4,3-a][1,4]diazepine 5-(2-chloro-phenyl)-1,6,7-trimethyl-1,3-dihydro-thieno[2,3-e][1,4]diazepin-2-one 4-(2-Chlorophenyl)-6H-thieno<3,2-f>-1,2,4-triazolo<4,3-a>-1,4-diazepine 4-(2-Chloro-phenyl)-9-cyclopropyl-2-iodo-6H-1-thia-5,7,8,9a-tetraaza-cyclopenta[e]azulene Acetic acid 5-(2-chloro-phenyl)-7-ethyl-2-oxo-2,3-dihydro-1H-thieno[2,3-e][1,4]diazepin-3-yl ester Acetic acid 5-(2-chloro-phenyl)-7-ethyl-1-methyl-2-oxo-2,3-dihydro-1H-thieno[2,3-e][1,4]diazepin-3-yl ester 2-ethyl-4-phenyl-6H-imidazo[1,2-a]thieno[3,2-f][1,4]diazepine